According to Array Technologies's latest financial reports and stock price the company's current number of shares outstanding is 151,175,000. At the end of 2023 the company had 151,175,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.15 B | 0.47% |
2022 | 0.15 B | 15.61% |
2021 | 0.13 B | 3.36% |
2020 | 0.12 B | -0.85% |
2019 | 0.12 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novartis NVS | 2,062,000,000 | 1,263.98% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | 949,379,000 | 528.00% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 253.89% | ๐บ๐ธ USA |
AstraZeneca AZN | 3,098,000,000 | 1,949.28% | ๐ฌ๐ง UK |
Onconova Therapeutics ONTX | 21,002,937 | -86.11% | ๐บ๐ธ USA |